Piracetam

Background: Antiepileptic drugs (AEDs) are the mainstay of epilepsy treatment. Since 1989, 18 new AEDs have been licensed for… Expand

Policy Points: Our study indicates that there are opportunities for cost savings in generic drug markets in Europe and the United… Expand

Summary:  Purpose: Disabling myoclonus is the main symptom in long‐standing Unverricht–Lundborg disease (ULD), and levetiracetam… Expand

A meta-analysis has been performed including nineteen double blind, placebo controlled studies with piracetam in patients… Expand

Background and Purpose In a prospective, double-blind, placebo-controlled study, it was investigated whether piracetam improves… Expand

We have previously shown that the novel anticonvulsant levetiracetam exerts potent anticonvulsant activity against both focal and… Expand

Background and Purpose Piracetam, a nootropic agent with neuroprotective properties, has been reported in pilot studies to… Expand

The experimental antiepileptic drug, levetiracetam (UCB L059), a piracetam analogue has been investigated in photosensitive… Expand

Preclinical research suggests that piracetam (a nootropic drug) may improve cognitive functions, but previous studies have failed… Expand

In an attempt to gain some insight into possible approaches to reducing age-related memory disturbances, aged Fischer 344 rats… Expand